Update shared on08 Oct 2025
Fair value Decreased 3.06%Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections.
What's in the News
- NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
- NINGI Research described Marex as having unreliable financials and a balance sheet described as "riddled with holes," calling the company a "financial house of cards" (Periodical).
- Marex Group plc issued third quarter 2025 earnings guidance, projecting revenue between $475 million and $485 million. Basic earnings per share are expected to be between $0.93 and $0.98, with diluted earnings per share expected at $0.88 to $0.93 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has fallen slightly from $50.89 to $49.33.
- Discount Rate remains unchanged at 13.28%.
- Revenue Growth forecast has improved modestly, with the contraction now less severe at -7.71% compared to the previous -8.35%.
- Net Profit Margin projection has declined slightly from 18.23% to 17.86%.
- Future P/E ratio estimate has decreased from 15.36x to 14.89x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.